Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT03010735

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2/3
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03010735
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03010735. Randomized; quadruple masking; primary purpose prevention. Start 2015-06 (registry gives no type); primary completion 2017-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)
Condition
Kidney Failure, Chronic
Intervention (Dietary supplement)
probiotics
Intervention (Dietary supplement)
Placebo
Lead sponsor
China Agricultural University (class: other)
Collaborator
Peking University Aerospace Center Hospital (class: other)
Collaborator
General Hospital of Chinese Armed Police Forces (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)
Collaborator
Beijing Biostats Technology Co. Ltd. (class: not stated)
Collaborator
Beijing Heyiyuan Biotech Co. Ltd. (class: other)

Record details

Record id
cardio:ct-nct03010735
Content hash
8f23d22cfa6b1fdc2a1164e3f5b28b894ce6e56266cbd9565e77781306e79c1a